- Home
- VYNE vs UTSI Comparison
VYNE vs UTSI Comparison
Compare VYNE & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- UTSI
- Stock Information
- Founded
- VYNE 2003
- UTSI 1991
- Country
- VYNE United States
- UTSI China
- Employees
- VYNE N/A
- UTSI N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- UTSI Telecommunications Equipment
- Sector
- VYNE Health Care
- UTSI Telecommunications
- Exchange
- VYNE Nasdaq
- UTSI Nasdaq
- Market Cap
- VYNE 24.3M
- UTSI 24.9M
- IPO Year
- VYNE 2018
- UTSI 2000
- Fundamental
- Price
- VYNE $0.35
- UTSI $2.40
- Analyst Decision
- VYNE Buy
- UTSI
- Analyst Count
- VYNE 2
- UTSI 0
- Target Price
- VYNE $8.00
- UTSI N/A
- AVG Volume (30 Days)
- VYNE 4.1M
- UTSI 5.4K
- Earning Date
- VYNE 08-14-2025
- UTSI 09-04-2025
- Dividend Yield
- VYNE N/A
- UTSI N/A
- EPS Growth
- VYNE N/A
- UTSI N/A
- EPS
- VYNE N/A
- UTSI N/A
- Revenue
- VYNE $476,000.00
- UTSI $10,878,000.00
- Revenue This Year
- VYNE $42.51
- UTSI N/A
- Revenue Next Year
- VYNE N/A
- UTSI N/A
- P/E Ratio
- VYNE N/A
- UTSI N/A
- Revenue Growth
- VYNE N/A
- UTSI N/A
- 52 Week Low
- VYNE $0.33
- UTSI $1.84
- 52 Week High
- VYNE $4.30
- UTSI $3.22
- Technical
- Relative Strength Index (RSI)
- VYNE 29.46
- UTSI 41.49
- Support Level
- VYNE $0.35
- UTSI $2.10
- Resistance Level
- VYNE $0.36
- UTSI $2.43
- Average True Range (ATR)
- VYNE 0.04
- UTSI 0.08
- MACD
- VYNE -0.02
- UTSI -0.01
- Stochastic Oscillator
- VYNE 1.79
- UTSI 62.94
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.